Royal Bank of Canada’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $414M | Sell |
7,506,786
-973,760
| -11% | -$52.8M | 0.07% | 251 |
|
|
2025
Q4 | $416M | Sell |
8,480,546
-343,193
| -4% | -$16M | 0.07% | 242 |
|
|
2025
Q3 | $381M | Buy |
8,823,739
+246,722
| +3% | +$9.64M | 0.06% | 271 |
|
|
2025
Q2 | $329M | Buy |
8,577,017
+995,938
| +13% | +$38.1M | 0.06% | 277 |
|
|
2025
Q1 | $294M | Buy |
7,581,079
+411,869
| +6% | +$15.1M | 0.06% | 274 |
|
|
2024
Q4 | $242M | Sell |
7,169,210
-3,679
| -0.1% | -$132K | 0.05% | 321 |
|
|
2024
Q3 | $293M | Buy |
7,172,889
+132,169
| +2% | +$5.41M | 0.06% | 283 |
|
|
2024
Q2 | $271M | Sell |
7,040,720
-1,106,688
| -14% | -$46.6M | 0.06% | 273 |
|
|
2024
Q1 | $349M | Sell |
8,147,408
-139,079
| -2% | -$5.74M | 0.08% | 227 |
|
|
2023
Q4 | $307M | Buy |
8,286,487
+206,590
| +3% | +$7.42M | 0.07% | 245 |
|
|
2023
Q3 | $293M | Buy |
8,079,897
+389,871
| +5% | +$13.8M | 0.08% | 229 |
|
|
2023
Q2 | $274M | Buy |
7,690,026
+5,526,736
| +255% | +$198M | 0.07% | 249 |
|
|
2023
Q1 | $77M | Buy |
2,163,290
+340,624
| +19% | +$11.9M | 0.02% | 531 |
|
|
2022
Q4 | $64M | Buy |
1,822,666
+78,278
| +4% | +$2.61M | 0.02% | 597 |
|
|
2022
Q3 | $51.3M | Buy |
1,744,388
+99,789
| +6% | +$3.78M | 0.02% | 624 |
|
|
2022
Q2 | $89.5M | Sell |
1,644,599
-10,339
| -0.6% | -$571K | 0.03% | 465 |
|
|
2022
Q1 | $90.1M | Sell |
1,654,938
-8,873
| -0.5% | -$482K | 0.02% | 534 |
|
|
2021
Q4 | $91.7M | Sell |
1,663,811
-103,603
| -6% | -$5.39M | 0.02% | 562 |
|
|
2021
Q3 | $84.4M | Buy |
1,767,414
+125,481
| +8% | +$6.3M | 0.02% | 550 |
|
|
2021
Q2 | $81.7M | Sell |
1,641,933
-6,163,692
| -79% | -$296M | 0.02% | 556 |
|
|
2021
Q1 | $348M | Sell |
7,805,625
-3,963,785
| -34% | -$180M | 0.1% | 180 |
|
|
2020
Q4 | $541M | Sell |
11,769,410
-682,266
| -5% | -$31.3M | 0.16% | 131 |
|
|
2020
Q3 | $586M | Sell |
12,451,676
-963,853
| -7% | -$48.3M | 0.21% | 105 |
|
|
2020
Q2 | $684M | Sell |
13,415,529
-357,266
| -3% | -$18.3M | 0.27% | 78 |
|
|
2020
Q1 | $652M | Buy |
13,772,795
+6,040,219
| +78% | +$322M | 0.31% | 71 |
|
|
2019
Q4 | $454M | Sell |
7,732,576
-190,864
| -2% | -$10.6M | 0.16% | 129 |
|
|
2019
Q3 | $423M | Sell |
7,923,440
-969,318
| -11% | -$49.9M | 0.17% | 117 |
|
|
2019
Q2 | $445M | Sell |
8,892,758
-116,852
| -1% | -$5.86M | 0.18% | 111 |
|
|
2019
Q1 | $471M | Sell |
9,009,610
-4,513,364
| -33% | -$226M | 0.2% | 102 |
|
|
2018
Q4 | $646M | Sell |
13,522,974
-2,461,103
| -15% | -$121M | 0.31% | 67 |
|
|
2018
Q3 | $803M | Sell |
15,984,077
-788,674
| -5% | -$40.1M | 0.33% | 60 |
|
|
2018
Q2 | $845M | Sell |
16,772,751
-261,321
| -2% | -$13.2M | 0.38% | 50 |
|
|
2018
Q1 | $832M | Sell |
17,034,072
-3,397,383
| -17% | -$158M | 0.37% | 48 |
|
|
2017
Q4 | $906M | Buy |
20,431,455
+13,515,851
| +195% | +$624M | 0.4% | 40 |
|
|
2017
Q3 | $351M | Sell |
6,915,604
-325,424
| -4% | -$16.5M | 0.17% | 117 |
|
|
2017
Q2 | $390M | Buy |
7,241,028
+274,561
| +4% | +$14.6M | 0.2% | 95 |
|
|
2017
Q1 | $367M | Buy |
6,966,467
+234,556
| +3% | +$11.9M | 0.2% | 92 |
|
|
2016
Q4 | $324M | Sell |
6,731,911
-109,561
| -2% | -$5.41M | 0.18% | 96 |
|
|
2016
Q3 | $369M | Sell |
6,841,472
-461,036
| -6% | -$25.3M | 0.21% | 85 |
|
|
2016
Q2 | $396M | Buy |
7,302,508
+134,942
| +2% | +$7.11M | 0.24% | 75 |
|
|
2016
Q1 | $363M | Sell |
7,167,566
-2,201,616
| -23% | -$110M | 0.23% | 75 |
|
|
2015
Q4 | $473M | Buy |
9,369,182
+674,466
| +8% | +$34.4M | 0.31% | 56 |
|
|
2015
Q3 | $418M | Sell |
8,694,716
-619,852
| -7% | -$32.3M | 0.31% | 54 |
|
|
2015
Q2 | $485M | Sell |
9,314,568
-271,874
| -3% | -$15.3M | 0.34% | 47 |
|
|
2015
Q1 | $553M | Sell |
9,586,442
-1,406,166
| -13% | -$80.6M | 0.39% | 38 |
|
|
2014
Q4 | $587M | Buy |
10,992,608
+188,872
| +2% | +$10.6M | 0.38% | 40 |
|
|
2014
Q3 | $621M | Sell |
10,803,736
-406,145
| -4% | -$24.9M | 0.42% | 35 |
|
|
2014
Q2 | $749M | Buy |
11,209,881
+6,307
| +0.1% | +$427K | 0.51% | 29 |
|
|
2014
Q1 | $748M | Sell |
11,203,574
-3,150,001
| -22% | -$213M | 0.55% | 26 |
|
|
2013
Q4 | $958M | Sell |
14,353,575
-66,010
| -0.5% | -$4.28M | 0.68% | 23 |
|
|
2013
Q3 | $904M | Sell |
14,419,585
-78,885
| -0.5% | -$5.08M | 0.69% | 24 |
|
|
2013
Q2 | $906M | Buy |
+14,498,470
| New | +$920M | 0.77% | 23 |
|
Other funds holding GSK
JEST
Royal Bank of Canada's GSK Position: Q1 2026 in Review
Royal Bank of Canada reduced its GSK (GSK) stake by 11% in Q1 2026, selling an estimated $52.8M and leaving 7,506,786 shares worth $414M. The position accounts for 0.07% of the portfolio, ranked #251.
Royal Bank of Canada first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $958M in Q4 2013. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Royal Bank of Canada held 7,506,786 shares of GSK worth $414M as of Q1 2026.
- Royal Bank of Canada sold 973,760 GSK shares in Q1 2026, an estimated $52.8M.
- GSK made up 0.07% of Royal Bank of Canada's portfolio in Q1 2026, its #251 holding.
- Royal Bank of Canada first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's GSK position peaked at $958M in Q4 2013.
- 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.